Functional characterization of G-protein-coupled receptors: A bioinformatics approach

Neuroscience

Volumn 277, Issue , 2014, Pages 764-779

  Tovo Rodrigues, L ^a,b   Roux, A ^b   Hutz, M H ^a   Rohde, L A ^a   Woods, A S ^b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Disordered proteins; GPCR; Linear motifs; Noncovalent interactions; Pest motifs

Indexed keywords

G PROTEIN COUPLED RECEPTOR; PDZ PROTEIN; PROTEIN 14 3 3; PROTEIN SH2; PROTEIN SH3;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; BIOINFORMATICS; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DIMERIZATION; HUMAN; INTRINSICALLY DISORDERED REGION; LIGAND BINDING; NERVE CELL PLASTICITY; PREDICTION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION; THIRD INTRACELLULAR LOOP; BINDING SITE; BIOLOGY; GENETICS; METABOLISM; PHYSIOLOGY; PROTEIN CONFORMATION;

BINDING SITES; COMPUTATIONAL BIOLOGY; DIMERIZATION; HUMANS; PROTEIN CONFORMATION; RECEPTORS, G-PROTEIN-COUPLED; SYNAPTIC TRANSMISSION;

EID: 84907020124     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2014.06.049     Document Type: Article

References (209)

1. Adams C.L., Cowen M.S., Short J.L., Lawrence A.J. Combined antagonism of glutamate mGlu5 and adenosine A2A receptors interact to regulate alcohol-seeking in rats. Int J Neuropsychopharmacol 2008, 11(2):229-241.
2. Agnati L.F., Ferre S., Lluis C., Franco R., Fuxe K. Molecular mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptors with examples from the striatopallidal GABA neurons. Pharmacol Rev 2003, 55(3):509-550.
3. Agnati L.F., et al. Allosteric modulation of dopamine D2 receptors by homocysteine. J Proteome Res 2006, 5(11):3077-3083.
4. Agnati L.F., et al. Structural plasticity in G-protein coupled receptors as demonstrated by the allosteric actions of homocysteine and computer-assisted analysis of disordered domains. Brain Res Rev 2008, 58(2):459-474.
5. Albizu L., Holloway T., Gonzalez-Maeso J., Sealfon S.C. Functional crosstalk and heteromerization of serotonin 5-HT2A and dopamine D2 receptors. Neuropharmacology 2011, 61(4):770-777.
6. Alen F., et al. Pharmacological activation of CB1 and D2 receptors in rats: predominant role of CB1 in the increase of alcohol relapse. Eur J Neurosci 2008, 27(12):3292-3298.
7. Baragli A., Alturaihi H., Watt H.L., Abdallah A., Kumar U. Heterooligomerization of human dopamine receptor 2 and somatostatin receptor 2 Co-immunoprecipitation and fluorescence resonance energy transfer analysis. Cell Signal 2007, 19(11):2304-2316.
8. Baxter H.C., et al. Specific 14-3-3 isoform detection and immunolocalization in prion diseases. Biochem Soc Trans 2002, 30(4):387-391.
9. Baxter H.C., Liu W.G., Forster J.L., Aitken A., Fraser J.R. Immunolocalisation of 14-3-3 isoforms in normal and scrapie-infected murine brain. Neuroscience 2002, 109(1):5-14.
10. Becamel C., et al. Interaction of serotonin 5-hydroxytryptamine type 2C receptors with PDZ10 of the multi-PDZ domain protein MUPP1. J Biol Chem 2001, 276(16):12974-12982.
11. Becker A., et al. Loss of locomotor sensitisation in response to morphine in D1 receptor deficient mice. Naunyn Schmiedebergs Arch Pharmacol 2001, 363(5):562-568.
12. Berg D., Holzmann C., Riess O. 14-3-3 proteins in the nervous system. Nat Rev Neurosci 2003, 4(9):752-762.
13. Biederer T., Sudhof T.C. Mints as adaptors. Direct binding to neurexins and recruitment of munc18. J Biol Chem 2000, 275(51):39803-39806.
14. Blom N., Gammeltoft S., Brunak S. Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. J Mol Biol 1999, 294(5):1351-1362.
15. Bockaert J., Fagni L., Dumuis A., Marin P. GPCR interacting proteins (GIP). Pharmacol Ther 2004, 103(3):203-221.
16. Bofill-Cardona E., et al. Binding of calmodulin to the D2-dopamine receptor reduces receptor signaling by arresting the G protein activation switch. J Biol Chem 2000, 275(42):32672-32680.
17. Bolbach G. Matrix-assisted laser desorption/ionization analysis of non-covalent complexes: fundamentals and applications. Curr Pharm Des 2005, 11:2535-2557.
18. Bordone L., Campbell C. DNA ligase III is degraded by calpain during cell death induced by DNA-damaging agents. J Biol Chem 2002, 277(29):26673-26680.
19. Borroto-Escuela D.O., et al. Dopamine D2 and 5-hydroxytryptamine 5-HT((2)A) receptors assemble into functionally interacting heteromers. Biochem Biophys Res Commun 2010, 401(4):605-610.
20. Borroto-Escuela D.O., et al. Moonlighting characteristics of G protein-coupled receptors: focus on receptor heteromers and relevance for neurodegeneration. IUBMB Life 2011, 63(7):463-472.
21. Borroto-Escuela D.O., et al. Dopamine D2 and D4 receptor heteromerization and its allosteric receptor-receptor interactions. Biochem Biophys Res Commun 2011, 404(4):928-934.
22. Borroto-Escuela D.O., et al. The existence of FGFR1-5-HT1A receptor heterocomplexes in midbrain 5-HT neurons of the rat: relevance for neuroplasticity. J Neurosci 2012, 32(18):6295-6303.
23. Boyer S.B., et al. Direct interaction of GABAB receptors with M2 muscarinic receptors enhances muscarinic signaling. J Neurosci 2009, 29(50):15796-15809.
24. Breit A., Lagace M., Bouvier M. Hetero-oligomerization between beta2- and beta3-adrenergic receptors generates a beta-adrenergic signaling unit with distinct functional properties. J Biol Chem 2004, 279(27):28756-28765.
25. Broadie K., Rushton E., Skoulakis E.M., Davis R.L. Leonardo, a Drosophila 14-3-3 protein involved in learning, regulates presynaptic function. Neuron 1997, 19(2):391-402.
26. Brown M.T., Cooper J.A. Regulation, substrates and functions of src. Biochim Biophys Acta 1996, 1287(2-3):121-149.
27. Cabello N., et al. Metabotropic glutamate type 5, dopamine D2 and adenosine A2a receptors form higher-order oligomers in living cells. J Neurochem 2009, 109(5):1497-1507.
28. Canals M., et al. Adenosine A2A-dopamine D2 receptor-receptor heteromerization: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer. J Biol Chem 2003, 278(47):46741-46749.
29. Cao Y., Xie K.Q., Zhu X.Z. The enhancement of dopamine D1 receptor desensitization by adenosine A1 receptor activation. Eur J Pharmacol 2007, 562(1-2):34-38.
30. Carriba P., et al. Striatal adenosine A2A and cannabinoid CB1 receptors form functional heteromeric complexes that mediate the motor effects of cannabinoids. Neuropsychopharmacology 2007, 32(11):2249-2259.
31. Cichewicz D.L. Synergistic interactions between cannabinoid and opioid analgesics. Life Sci 2004, 74(11):1317-1324.
32. Ciruela F., et al. Metabotropic glutamate 1alpha and adenosine A1 receptors assemble into functionally interacting complexes. J Biol Chem 2001, 276(21):18345-18351.
33. Ciruela F., et al. Combining mass spectrometry and pull-down techniques for the study of receptor heteromerization. Direct epitope-epitope electrostatic interactions between adenosine A2A and dopamine D2 receptors. Anal Chem 2004, 76(18):5354-5363.
34. Ciruela F., et al. Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers. J Neurosci 2006, 26(7):2080-2087.
35. Citri A., Malenka R.C. Synaptic plasticity: multiple forms, functions, and mechanisms. Neuropsychopharmacology 2008, 33(1):18-41.
36. Couve A., et al. Association of GABA(B) receptors and members of the 14-3-3 family of signaling proteins. Mol Cell Neurosci 2001, 17(2):317-328.
37. Davies A., Gowen B.E., Krebs A.M., Schertler G.F., Saibil H.R. Three-dimensional structure of an invertebrate rhodopsin and basis for ordered alignment in the photoreceptor membrane. J Mol Biol 2001, 314(3):455-463.
38. Derangeon M., et al. 5-HT4 and 5-HT2 receptors antagonistically influence gap junctional coupling between rat auricular myocytes. J Mol Cell Cardiol 2010, 48(1):220-229.
39. DiAntonio A., et al. Ubiquitination-dependent mechanisms regulate synaptic growth and function. Nature 2001, 412(6845):449-452.
40. Diaz-Cabiale Z., et al. Neurotensin-induced modulation of dopamine D2 receptors and their function in rat striatum: counteraction by a NTR1-like receptor antagonist. Neuroreport 2002, 13(6):763-766.
41. Dinkel H., et al. ELM - the database of eukaryotic linear motifs. Nucleic Acids Res 2012, 40(Database issue):D242-251.
42. Domenici M.R., et al. Permissive role of adenosine A2A receptors on metabotropic glutamate receptor 5 (mGluR5)-mediated effects in the striatum. J Neurochem 2004, 90(5):1276-1279.
43. Dong C., Filipeanu C.M., Duvernay M.T., Wu G. Regulation of G protein-coupled receptor export trafficking. Biochim Biophys Acta 2007, 1768(4):853-870.
44. Dunker A.K., et al. Intrinsically disordered protein. J Mol Graph Model 2001, 19(1):26-59.
45. Ellis J., Pediani J.D., Canals M., Milasta S., Milligan G. Orexin-1 receptor-cannabinoid CB1 receptor heterodimerization results in both ligand-dependent and -independent coordinated alterations of receptor localization and function. J Biol Chem 2006, 281(50):38812-38824.
46. Fang M., et al. Synaptic PDZ domain-mediated protein interactions are disrupted by inhalational anesthetics. J Biol Chem 2003, 278(38):36669-36675.
47. Ferrada C., et al. Interactions between histamine H3 and dopamine D2 receptors and the implications for striatal function. Neuropharmacology 2008, 55(2):190-197.
48. Ferre S., et al. Adenosine A1 receptor-mediated modulation of dopamine D1 receptors in stably cotransfected fibroblast cells. J Biol Chem 1998, 273(8):4718-4724.
49. Ferre S., et al. Adenosine A2A and group I metabotropic glutamate receptors synergistically modulate the binding characteristics of dopamine D2 receptors in the rat striatum. Neuropharmacology 1999, 38(1):129-140.
50. Ferre S., et al. Adenosine A2A-dopamine D2 receptor-receptor heteromers. Targets for neuro-psychiatric disorders. Parkinsonism Relat Disord 2004, 10(5):265-271.
51. Fiorentini C., et al. Reciprocal regulation of dopamine D1 and D3 receptor function and trafficking by heterodimerization. Mol Pharmacol 2008, 74(1):59-69.
52. Foote M., Zhou Y. 14-3-3 proteins in neurological disorders. Int J Biochem Mol Biol 2012, 3(2):152-164.
53. Fotiadis D., et al. Atomic-force microscopy: rhodopsin dimers in native disc membranes. Nature 2003, 421(6919):127-128.
54. Franco R., et al. Evidence for adenosine/dopamine receptor interactions: indications for heteromerization. Neuropsychopharmacology 2000, 23(4 Suppl):S50-S59.
55. Fuxe K., et al. Adenosine A2A and dopamine D2 heteromeric receptor complexes and their function. J Mol Neurosci 2005, 26(2-3):209-220.
56. Fuxreiter M., Tompa P., Simon I. Local structural disorder imparts plasticity on linear motifs. Bioinformatics 2007, 23(8):950-956.
57. Gao J., Xu D. Correlation between posttranslational modification and intrinsic disorder in protein. Pac Symp Biocomput 2012, 94-103.
58. Garcia-Alai M.M., et al. Molecular basis for phosphorylation-dependent, PEST-mediated protein turnover. Structure 2006, 14(2):309-319.
59. Garner C.C., Kindler S., Gundelfinger E.D. Molecular determinants of presynaptic active zones. Curr Opin Neurobiol 2000, 10(3):321-327.
60. Garner C.C., Nash J., Huganir R.L. PDZ domains in synapse assembly and signalling. Trends Cell Biol 2000, 10(7):274-280.
61. George S.R., et al. Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties. J Biol Chem 2000, 275(34):26128-26135.
62. Gines S., et al. Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes. Proc Natl Acad Sci U S A 2000, 97(15):8606-8611.
63. Glass M., Felder C.C. Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor. J Neurosci 1997, 17(14):5327-5333.
64. Glass M.J., Pickel V.M. Alpha(2A)-adrenergic receptors are present in mu-opioid receptor containing neurons in rat medial nucleus tractus solitarius. Synapse 2002, 43(3):208-218.
65. Gomes I., et al. Heterodimerization of mu and delta opioid receptors: a role in opiate synergy. J Neurosci 2000, 20(22):RC110.
66. Gonzalez S., et al. Circadian-related heteromerization of adrenergic and dopamine D(4) receptors modulates melatonin synthesis and release in the pineal gland. PLoS Biol 2012, 10(6):e1001347.
67. Gonzalez-Maeso J., et al. Identification of a serotonin/glutamate receptor complex implicated in psychosis. Nature 2008, 452(7183):93-97.
68. Grant M., Alturaihi H., Jaquet P., Collier B., Kumar U. Cell growth inhibition and functioning of human somatostatin receptor type 2 are modulated by receptor heterodimerization. Mol Endocrinol 2008, 22(10):2278-2292.
69. Gregory M.A., Hann S.R. C-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells. Mol Cell Biol 2000, 20(7):2423-2435.
70. Guo W., Shi L., Filizola M., Weinstein H., Javitch J.A. Crosstalk in G protein-coupled receptors: changes at the transmembrane homodimer interface determine activation. Proc Natl Acad Sci U S A 2005, 102(48):17495-17500.
71. Guo W., et al. Dopamine D2 receptors form higher order oligomers at physiological expression levels. EMBO J 2008, 27(17):2293-2304.
72. Hague C., Uberti M.A., Chen Z., Hall R.A., Minneman K.P. Cell surface expression of alpha1D-adrenergic receptors is controlled by heterodimerization with alpha1B-adrenergic receptors. J Biol Chem 2004, 279(15):15541-15549.
73. Hall R.A., et al. The beta2-adrenergic receptor interacts with the Na+/H+-exchanger regulatory factor to control Na+/H+ exchange. Nature 1998, 392(6676):626-630.
74. Han Y., Moreira I.S., Urizar E., Weinstein H., Javitch J.A. Allosteric communication between protomers of dopamine class A GPCR dimers modulates activation. Nat Chem Biol 2009, 5(9):688-695.
75. Hebert T.E., et al. A peptide derived from a beta2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. J Biol Chem 1996, 271(27):16384-16392.
76. Hilairet S., Bouaboula M., Carriere D., Le Fur G., Casellas P. Hypersensitization of the Orexin 1 receptor by the CB1 receptor: evidence for cross-talk blocked by the specific CB1 antagonist, SR141716. J Biol Chem 2003, 278(26):23731-23737.
77. Hillion J., et al. Coaggregation, cointernalization, and codesensitization of adenosine A2A receptors and dopamine D2 receptors. J Biol Chem 2002, 277(20):18091-18097.
78. Hirono M., Yoshioka T., Konishi S. GABA(B) receptor activation enhances mGluR-mediated responses at cerebellar excitatory synapses. Nat Neurosci 2001, 4(12):1207-1216.
79. Hojo M., et al. Mu-Opioid receptor forms a functional heterodimer with cannabinoid CB1 receptor: electrophysiological and FRET assay analysis. J Pharmacol Sci 2008, 108(3):308-319.
80. Hu L.A., et al. Beta 1-adrenergic receptor association with PSD-95. Inhibition of receptor internalization and facilitation of beta 1-adrenergic receptor interaction with N-methyl-d-aspartate receptors. J Biol Chem 2000, 275(49):38659-38666.
81. Huang Y., et al. DisMeta: a meta server for construct design and optimization. Methods Mol Biol 2014, 1091:3-16.
82. Jaakola V.P. G protein-coupled receptors show unusual patterns of intrinsic unfolding. Protein Eng Des Sel 2005, 18(2):103-110.
83. Jackson S.N., Wang H.Y., Woods A.S. Study of the fragmentation patterns of the phosphate-arginine noncovalent bond. J Proteome Res 2005, 4(6):2360-2363.
84. Jackson S.N., Wang H.Y., Yergey A., Woods A.S. Phosphate stabilization of intermolecular interactions. J Proteome Res 2006, 5(1):122-126.
85. Jaquet P., et al. Efficacy of chimeric molecules directed towards multiple somatostatin and dopamine receptors on inhibition of GH and prolactin secretion from GH-secreting pituitary adenomas classified as partially responsive to somatostatin analog therapy. Eur J Endocrinol 2005, 153(1):135-141.
86. Jarrahian A., Watts V.J., Barker E.L. D2 dopamine receptors modulate Galpha-subunit coupling of the CB1 cannabinoid receptor. J Pharmacol Exp Ther 2004, 308(3):880-886.
87. Jones K.A., et al. GABA(B) receptors function as a heteromeric assembly of the subunits GABA(B)R1 and GABA(B)R2. Nature 1998, 396(6712):674-679.
88. Jordan B.A., Devi L.A. G-protein-coupled receptor heterodimerization modulates receptor function. Nature 1999, 399(6737):697-700.
89. Jordan B.A., Trapaidze N., Gomes I., Nivarthi R., Devi L.A. Oligomerization of opioid receptors with beta 2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation. Proc Natl Acad Sci U S A 2001, 98(1):343-348.
90. Jordan B.A., Gomes I., Rios C., Filipovska J., Devi L.A. Functional interactions between mu opioid and alpha 2A-adrenergic receptors. Mol Pharmacol 2003, 64(6):1317-1324.
91. Kachroo A., et al. Interactions between metabotropic glutamate 5 and adenosine A2A receptors in normal and parkinsonian mice. J Neurosci 2005, 25(45):10414-10419.
92. Karnik S.S., Gogonea C., Patil S., Saad Y., Takezako T. Activation of G-protein-coupled receptors: a common molecular mechanism. Trends Endocrinol Metab 2003, 14(9):431-437.
93. Karoor V., Wang L., Wang H.Y., Malbon C.C. Insulin stimulates sequestration of beta-adrenergic receptors and enhanced association of beta-adrenergic receptors with Grb2 via tyrosine 350. J Biol Chem 1998, 273(49):33035-33041.
94. Kaupmann K., et al. GABA(B)-receptor subtypes assemble into functional heteromeric complexes. Nature 1998, 396(6712):683-687.
95. Kearn C.S., Blake-Palmer K., Daniel E., Mackie K., Glass M. Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: a mechanism for receptor cross-talk?. Mol Pharmacol 2005, 67(5):1697-1704.
96. Kenakin T., et al. International Workshop at the Nobel Forum, Karolinska Institutet on G protein-coupled receptors: finding the words to describe monomers, oligomers, and their molecular mechanisms and defining their meaning. Can a consensus be reached?. J Recept Signal Transduct Res 2010, 30:284-286.
97. Kim E.J., Park J.S., Um S.J. Identification and characterization of HIPK2 interacting with p73 and modulating functions of the p53 family in vivo. J Biol Chem 2002, 277(35):32020-32028.
98. Klco J.M., Lassere T.B., Baranski T.J. C5a receptor oligomerization. I. Disulfide trapping reveals oligomers and potential contact surfaces in a G protein-coupled receptor. J Biol Chem 2003, 278(37):35345-35353.
99. Kuner R., et al. Role of heteromer formation in GABAB receptor function. Science 1999, 283(5398):74-77.
100. Kunishima N., et al. Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor. Nature 2000, 407(6807):971-977.
101. Lavoie C., et al. Beta 1/beta 2-adrenergic receptor heterodimerization regulates beta 2-adrenergic receptor internalization and ERK signaling efficacy. J Biol Chem 2002, 277(38):35402-35410.
102. Lee S.P., et al. Dopamine D1 and D2 receptor Co-activation generates a novel phospholipase C-mediated calcium signal. J Biol Chem 2004, 279(34):35671-35678.
103. Lefkowitz R.J. Historical review: a brief history and personal retrospective of seven-transmembrane receptors. Trends Pharmacol Sci 2004, 25(8):413-422.
104. Levoye A., et al. The orphan GPR50 receptor specifically inhibits MT1 melatonin receptor function through heterodimerization. EMBO J 2006, 25(13):3012-3023.
105. Li Y., Wu Y., Zhou Y. Modulation of inactivation properties of CaV2.2 channels by 14-3-3 proteins. Neuron 2006, 51(6):755-771.
106. Liang Y., et al. Organization of the G protein-coupled receptors rhodopsin and opsin in native membranes. J Biol Chem 2003, 278(24):21655-21662.
107. Liu J., et al. Src homology 3 binding sites in the P2Y2 nucleotide receptor interact with Src and regulate activities of Src, proline-rich tyrosine kinase 2, and growth factor receptors. J Biol Chem 2004, 279(9):8212-8218.
108. Lopez de Maturana R., Sanchez-Pernaute R. Regulation of corticostriatal synaptic plasticity by G protein-coupled receptors. CNS Neurol Disord Drug Targets 2010, 9(5):601-615.
109. Lovinger D.M. Neurotransmitter roles in synaptic modulation, plasticity and learning in the dorsal striatum. Neuropharmacology 2010, 58(7):951-961.
110. Lukasiewicz S., Faron-Gorecka A., Dobrucki J., Polit A., Dziedzicka-Wasylewska M. Studies on the role of the receptor protein motifs possibly involved in electrostatic interactions on the dopamine D1 and D2 receptor oligomerization. FEBS J 2009, 276(3):760-775.
111. Lukasiewicz S., et al. Hetero-dimerization of serotonin 5-HT(2A) and dopamine D(2) receptors. Biochim Biophys Acta 2010, 1803(12):1347-1358.
112. Maggio R., Scarselli M., Novi F., Millan M.J., Corsini G.U. Potent activation of dopamine D3/D2 heterodimers by the antiparkinsonian agents, S32504, pramipexole and ropinirole. J Neurochem 2003, 87(3):631-641.
113. Maness P.F., Beggs H.E., Klinz S.G., Morse W.R. Selective neural cell adhesion molecule signaling by Src family tyrosine kinases and tyrosine phosphatases. Perspect Dev Neurobiol 1996, 4(2-3):169-181.
114. Marcellino D., et al. Identification of dopamine D1-D3 receptor heteromers. Indications for a role of synergistic D1-D3 receptor interactions in the striatum. J Biol Chem 2008, 283(38):26016-26025.
115. Marchal C., Haguenauer-Tsapis R., Urban-Grimal D. A PEST-like sequence mediates phosphorylation and efficient ubiquitination of yeast uracil permease. Mol Cell Biol 1998, 18(1):314-321.
116. Margeta-Mitrovic M., Jan Y.N., Jan L.Y. A trafficking checkpoint controls GABA(B) receptor heterodimerization. Neuron 2000, 27(1):97-106.
117. Martin H., Rostas J., Patel Y., Aitken A. Subcellular localisation of 14-3-3 isoforms in rat brain using specific antibodies. J Neurochem 1994, 63(6):2259-2265.
118. Martin A.B., et al. Expression and function of CB1 receptor in the rat striatum: localization and effects on D1 and D2 dopamine receptor-mediated motor behaviors. Neuropsychopharmacology 2008, 33(7):1667-1679.
119. Maurel D., et al. Cell-surface protein-protein interaction analysis with time-resolved FRET and snap-tag technologies: application to GPCR oligomerization. Nat Methods 2008, 5(6):561-567.
120. McVey M., et al. Monitoring receptor oligomerization using time-resolved fluorescence resonance energy transfer and bioluminescence resonance energy transfer. The human delta -opioid receptor displays constitutive oligomerization at the cell surface, which is not regulated by receptor occupancy. J Biol Chem 2001, 276(17):14092-14099.
121. Mercier J.F., Salahpour A., Angers S., Breit A., Bouvier M. Quantitative assessment of beta 1- and beta 2-adrenergic receptor homo- and heterodimerization by bioluminescence resonance energy transfer. J Biol Chem 2002, 277(47):44925-44931.
122. Meschler J.P., Howlett A.C. Signal transduction interactions between CB1 cannabinoid and dopamine receptors in the rat and monkey striatum. Neuropharmacology 2001, 40(7):918-926.
123. Milligan G. G protein-coupled receptor hetero-dimerization: contribution to pharmacology and function. Br J Pharmacol 2009, 158(1):5-14.
124. Missler M., et al. Alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis. Nature 2003, 423(6943):939-948.
125. Mohamed A.S., Rivas-Plata K.A., Kraas J.R., Saleh S.M., Swope S.L. Src-class kinases act within the agrin/MuSK pathway to regulate acetylcholine receptor phosphorylation, cytoskeletal anchoring, and clustering. J Neurosci 2001, 21(11):3806-3818.
126. Moreno J.L., et al. Identification of three residues essential for 5-HT2A-mGlu2 receptor heteromerization and its psychoactive behavioral function. J Biol Chem 2012, 287(53):44301-44319.
127. Navarro G., et al. Detection of heteromers formed by cannabinoid CB1, dopamine D2, and adenosine A2A G-protein-coupled receptors by combining bimolecular fluorescence complementation and bioluminescence energy transfer. ScientificWorldJournal 2008, 8:1088-1097.
128. Navarro G., et al. Interactions between intracellular domains as key determinants of the quaternary structure and function of receptor heteromers. J Biol Chem 2010, 285(35):27346-27359.
129. Ng G.Y., et al. Identification of a GABAB receptor subunit, gb2, required for functional GABAB receptor activity. J Biol Chem 1999, 274(12):7607-7610.
130. Nishi A., et al. Metabotropic mGlu5 receptors regulate adenosine A2A receptor signaling. Proc Natl Acad Sci U S A 2003, 100(3):1322-1327.
131. Nourry C., Grant S.G., Borg J.P. PDZ domain proteins: plug and play!. Sci STKE 2003, 2003(179):RE7.
132. O'Dowd B.F., Ji X., Nguyen T., George S.R. Two amino acids in each of D1 and D2 dopamine receptor cytoplasmic regions are involved in D1-D2 heteromer formation. Biochem Biophys Res Commun 2012, 417(1):23-28.
133. Okamoto M., Sudhof T.C. Mints, Munc18-interacting proteins in synaptic vesicle exocytosis. J Biol Chem 1997, 272(50):31459-31464.
134. Olayioye M.A., et al. Threonine 391 phosphorylation of the human prolactin receptor mediates a novel interaction with 14-3-3 proteins. J Biol Chem 2003, 278(35):32929-32935.
135. Oldenhof J., et al. SH3 binding domains in the dopamine D4 receptor. Biochemistry 1998, 37(45):15726-15736.
136. Otaki J.M., Firestein S. Length analyses of mammalian G-protein-coupled receptors. J Theor Biol 2001, 211(2):77-100.
137. Pawson T., Scott J.D. Signaling through scaffold, anchoring, and adaptor proteins. Science 1997, 278(5346):2075-2080.
138. Perreault M.L., Hasbi A., Alijaniaram M., O'Dowd B.F., George S.R. Reduced striatal dopamine D1-D2 receptor heteromer expression and behavioural subsensitivity in juvenile rats. Neuroscience 2012, 225:130-139.
139. Perroy J., et al. PICK1 is required for the control of synaptic transmission by the metabotropic glutamate receptor 7. EMBO J 2002, 21(12):2990-2999.
140. Pfeiffer M., et al. Homo- and heterodimerization of somatostatin receptor subtypes. Inactivation of sst(3) receptor function by heterodimerization with sst(2A). J Biol Chem 2001, 276(17):14027-14036.
141. Pfeiffer M., et al. Heterodimerization of somatostatin and opioid receptors cross-modulates phosphorylation, internalization, and desensitization. J Biol Chem 2002, 277(22):19762-19772.
142. Pickel V.M., Chan J., Kearn C.S., Mackie K. Targeting dopamine D2 and cannabinoid-1 (CB1) receptors in rat nucleus accumbens. J Comp Neurol 2006, 495(3):299-313.
143. Popoli P., et al. The selective mGlu(5) receptor agonist CHPG inhibits quinpirole-induced turning in 6-hydroxydopamine-lesioned rats and modulates the binding characteristics of dopamine D(2) receptors in the rat striatum: interactions with adenosine A(2a) receptors. Neuropsychopharmacology 2001, 25(4):505-513.
144. Prinster S.C., Hague C., Hall R.A. Heterodimerization of g protein-coupled receptors: specificity and functional significance. Pharmacol Rev 2005, 57(3):289-298.
145. Ramsay D., Kellett E., McVey M., Rees S., Milligan G. Homo- and hetero-oligomeric interactions between G-protein-coupled receptors in living cells monitored by two variants of bioluminescence resonance energy transfer (BRET): hetero-oligomers between receptor subtypes form more efficiently than between less closely related sequences. Biochem J 2002, 365(Pt 2):429-440.
146. Rashid A.J., et al. D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum. Proc Natl Acad Sci U S A 2007, 104(2):654-659.
147. Rasmussen B.A., Kim E., Unterwald E.M., Rawls S.M. Methanandamide attenuates cocaine-induced hyperthermia in rats by a cannabinoid CB(1)-dopamine D(2) receptor mechanism. Brain Res 2009, 1206:7-14.
148. Rechsteiner M., Rogers S.W. PEST sequences and regulation by proteolysis. Trends Biochem Sci 1996, 21(7):267-271.
149. Renner U., et al. Heterodimerization of serotonin receptors 5-HT1A and 5-HT7 differentially regulates receptor signalling and trafficking. J Cell Sci 2012, 125(Pt 10):2486-2499.
150. Rice P., Longden I., Bleasby A. EMBOSS: the European Molecular Biology Open Software Suite. Trends Genet 2000, 16(6):276-277.
151. Richman J.G., et al. Agonist-regulated interaction between alpha2-adrenergic receptors and spinophilin. J Biol Chem 2001, 276(18):15003-15008.
152. Rios C., Gomes I., Devi L.A. Mu opioid and CB1 cannabinoid receptor interactions: reciprocal inhibition of receptor signaling and neuritogenesis. Br J Pharmacol 2006, 148(4):387-395.
153. Ritter S.L., Hall R.A. Fine-tuning of GPCR activity by receptor-interacting proteins. Nat Rev Mol Cell Biol 2009, 10(12):819-830.
154. Rocheville M., et al. Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity. Science 2000, 288(5463):154-157.
155. Rocheville M., et al. Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers. J Biol Chem 2000, 275(11):7862-7869.
156. Rodrigues R.J., Alfaro T.M., Rebola N., Oliveira C.R., Cunha R.A. Co-localization and functional interaction between adenosine A(2A) and metabotropic group 5 receptors in glutamatergic nerve terminals of the rat striatum. J Neurochem 2005, 92(3):433-441.
157. Rogers S., Wells R., Rechsteiner M. Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis. Science 1986, 234(4774):364-368.
158. Rozenfeld R., et al. Receptor heteromerization expands the repertoire of cannabinoid signaling in rodent neurons. PLoS One 2012, 7(1):e29239.
159. Sadasivam G., et al. Src-family kinases stabilize the neuromuscular synapse in vivo via protein interactions, phosphorylation, and cytoskeletal linkage of acetylcholine receptors. J Neurosci 2005, 25(45):10479-10493.
160. Salahpour A., et al. Homodimerization of the beta2-adrenergic receptor as a prerequisite for cell surface targeting. J Biol Chem 2004, 279(32):33390-33397.
161. Saunders C., Limbird L.E. Microtubule-dependent regulation of alpha(2B) adrenergic receptors in polarized MDCKII cells requires the third intracellular loop but not G protein coupling. Mol Pharmacol 2000, 57(1):44-52.
162. Scarselli M., et al. D2/D3 dopamine receptor heterodimers exhibit unique functional properties. J Biol Chem 2001, 276(32):30308-30314.
163. Schug K.A., Lindner W. Noncovalent binding between guanidinium and anionic groups: focus on biological- and synthetic-based arginine/guanidinium interactions with phosph[on]ate and sulf[on]ate residues. Chem Rev 2005, 105(1):67-114.
164. Singh G.P., Ganapathi M., Sandhu K.S., Dash D. Intrinsic unstructuredness and abundance of PEST motifs in eukaryotic proteomes. Proteins 2006, 62(2):309-315.
165. Smith F.D., Oxford G.S., Milgram S.L. Association of the D2 dopamine receptor third cytoplasmic loop with spinophilin, a protein phosphatase-1-interacting protein. J Biol Chem 1999, 274(28):19894-19900.
166. So C.H., et al. D1 and D2 dopamine receptors form heterooligomers and cointernalize after selective activation of either receptor. Mol Pharmacol 2005, 68(3):568-578.
167. So C.H., et al. Calcium signaling by dopamine D5 receptor and D5-D2 receptor hetero-oligomers occurs by a mechanism distinct from that for dopamine D1-D2 receptor hetero-oligomers. Mol Pharmacol 2009, 75(4):843-854.
168. Soria G., et al. Adenosine A2A receptors are involved in physical dependence and place conditioning induced by THC. Eur J Neurosci 2004, 20(8):2203-2213.
169. Springael J.Y., Urizar E., Costagliola S., Vassart G., Parmentier M. Allosteric properties of G protein-coupled receptor oligomers. Pharmacol Ther 2007, 115(3):410-418.
170. Stanasila L., Perez J.B., Vogel H., Cotecchia S. Oligomerization of the alpha 1a- and alpha 1b-adrenergic receptor subtypes. Potential implications in receptor internalization. J Biol Chem 2003, 278(41):40239-40251.
171. Tan M., Walwyn W.M., Evans C.J., Xie C.W. P38 MAPK and beta-arrestin 2 mediate functional interactions between endogenous micro-opioid and alpha2A-adrenergic receptors in neurons. J Biol Chem 2009, 284(10):6270-6281.
172. Tanganelli S., et al. Striatal plasticity at the network level. Focus on adenosine A2A and D2 interactions in models of Parkinson's disease. Parkinsonism Relat Disord 2004, 10(5):273-280.
173. Tazawa H., Takahashi S., Zilliacus J. Interaction of the parathyroid hormone receptor with the 14-3-3 protein. Biochim Biophys Acta 2003, 1620(1-3):32-38.
174. Tebano M.T., et al. Adenosine A2A receptors enable the synaptic effects of cannabinoid CB1 receptors in the rodent striatum. J Neurochem 2009, 110(6):1921-1930.
175. Thomas S.M., Brugge J.S. Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol 1997, 13:513-609.
176. Thomas S.M., Soriano P., Imamoto A. Specific and redundant roles of Src and Fyn in organizing the cytoskeleton. Nature 1995, 376(6537):267-271.
177. Tien L.T., Ho I.K., Ma T. Methamphetamine-induced expression of zif268 mRNA is prevented by haloperidol in mice lacking mu-opioid receptor. Neurotoxicology 2010, 31(3):326-330.
178. Tonazzini I., Trincavelli M.L., Montali M., Martini C. Regulation of A1 adenosine receptor functioning induced by P2Y1 purinergic receptor activation in human astroglial cells. J Neurosci Res 2008, 86(13):2857-2866.
179. Torvinen M., et al. Adenosine A2A receptor and dopamine D3 receptor interactions: evidence of functional A2A/D3 heteromeric complexes. Mol Pharmacol 2005, 67(2):400-407.
180. Uberti M.A., Hall R.A., Minneman K.P. Subtype-specific dimerization of alpha 1-adrenoceptors: effects on receptor expression and pharmacological properties. Mol Pharmacol 2003, 64(6):1379-1390.
181. Uberti M.A., Hague C., Oller H., Minneman K.P., Hall R.A. Heterodimerization with beta2-adrenergic receptors promotes surface expression and functional activity of alpha1D-adrenergic receptors. J Pharmacol Exp Ther 2005, 313(1):16-23.
182. Ulibarri I., Garcia-Sevilla J.A., Ugedo L. Modulation of brain alpha 2-adrenoceptor and mu-opioid receptor densities during morphine dependence and spontaneous withdrawal in rats. Naunyn Schmiedebergs Arch Pharmacol 1987, 336(5):530-537.
183. Umemori H., Sato S., Yagi T., Aizawa S., Yamamoto T. Initial events of myelination involve Fyn tyrosine kinase signalling. Nature 1994, 367(6463):572-576.
184. van Ham M., Hendriks W. PDZ domains-glue and guide. Mol Biol Rep 2003, 30(2):69-82.
185. Venema R.C., et al. Angiotensin II-induced association of phospholipase Cgamma1 with the G-protein-coupled AT1 receptor. J Biol Chem 1998, 273(13):7703-7708.
186. von Euler G. Biochemical characterization of the intramembrane interaction between neurotensin and dopamine D2 receptors in the rat brain. Brain Res 1991, 561(1):93-98.
187. Wang D., Sadee W., Quillan J.M. Calmodulin binding to G protein-coupling domain of opioid receptors. J Biol Chem 1999, 274(31):22081-22088.
188. Ward R.J., Pediani J.D., Milligan G. Heteromultimerization of cannabinoid CB(1) receptor and orexin OX(1) receptor generates a unique complex in which both protomers are regulated by orexin A. J Biol Chem 2011, 286(43):37414-37428.
189. White J.H., et al. Heterodimerization is required for the formation of a functional GABA(B) receptor. Nature 1998, 396(6712):679-682.
190. Woods A.S. The mighty arginine, the stable quaternary amines, the powerful aromatics and the aggressive phosphate: their role in the noncovalent minuet. J Proteome Res 2004, 3:478-484.
191. 4 receptor, the ultimate disordered protein. J Recept Signal Transduct 2010, 30:331-336.
192. Woods A.S., Ferre S. Amazing stability of the arginine-phosphate electrostatic interaction. J Proteome Res 2005, 4(4):1397-1402.
193. Woods A.S., Huestis M.A. A study of peptide-peptide interaction by MALDI. JASMS 2001, 12:88-96.
194. Woods A.S., Jackson S.N. How adenylate cyclase choreographs the pas de deux of the Receptors heteromerization danc. Neuroscience 2013, 238:335-344.
195. Woods A.S., et al. Role of electrostatic interaction in receptor-receptor heteromerization. J Mol Neurosci 2005, 26(2-3):125-132.
196. Wright P.E., Dyson H.J. Linking folding and binding. Curr Opin Struct Biol 2009, 19:31-38.
197. Xie Z., Lee S.P., O'Dowd B.F., George S.R. Serotonin 5-HT1B and 5-HT1D receptors form homodimers when expressed alone and heterodimers when co-expressed. FEBS Lett 1999, 456(1):63-67.
198. Xu J., et al. Heterodimerization of alpha 2A- and beta 1-adrenergic receptors. J Biol Chem 2003, 278(12):10770-10777.
199. Xue B., et al. PONDR-FIT: a meta-predictor of intrinsically disordered amino acids. Biochim Biophys Acta 2010, 1804(4):996-1010.
200. Yabuuchi K., et al. Role of adenosine A1 receptors in the modulation of dopamine D1 and adenosine A2A receptor signaling in the neostriatum. Neuroscience 2006, 141(1):19-25.
201. Yang Z.R., Thomson R., McNeil P., Esnouf R.M. RONN: the bio-basis function neural network technique applied to the detection of natively disordered regions in proteins. Bioinformatics 2005, 21(16):3369-3376.
202. Yoshioka K., Saitoh O., Nakata H. Heteromeric association creates a P2Y-like adenosine receptor. Proc Natl Acad Sci U S A 2001, 98(13):7617-7622.
203. Yoshioka K., Hosoda R., Kuroda Y., Nakata H. Hetero-oligomerization of adenosine A1 receptors with P2Y1 receptors in rat brains. FEBS Lett 2002, 531(2):299-303.
204. Zeng F.Y., Wess J. Identification and molecular characterization of m3 muscarinic receptor dimers. J Biol Chem 1999, 274(27):19487-19497.
205. Zerangue N., Schwappach B., Jan Y.N., Jan L.Y. A new ER trafficking signal regulates the subunit stoichiometry of plasma membrane K(ATP) channels. Neuron 1999, 22(3):537-548.
206. Zerangue N., et al. Analysis of endoplasmic reticulum trafficking signals by combinatorial screening in mammalian cells. Proc Natl Acad Sci U S A 2001, 98(5):2431-2436.
207. Zhang Y.Q., Limbird L.E. Hetero-oligomers of alpha2A-adrenergic and mu-opioid receptors do not lead to transactivation of G-proteins or altered endocytosis profiles. Biochem Soc Trans 2004, 32(Pt 5):856-860.
208. Zhou Y., et al. A dynamically regulated 14-3-3, Slob, and Slowpoke potassium channel complex in Drosophila presynaptic nerve terminals. Neuron 1999, 22(4):809-818.
209. Zhu W.Z., et al. Heterodimerization of beta1- and beta2-adrenergic receptor subtypes optimizes beta-adrenergic modulation of cardiac contractility. Circ Res 2005, 97(3):244-251.